Article By:
The Fly
Tuesday, May 10, 2016 11:48 AM EDT
Alexza Pharmaceuticals and Grupo Ferrer Internacional announced that they have entered into a definitive agreement under which Ferrer Pharma, a wholly-owned subsidiary of Ferrer, will acquire Alexza for $0.90 per share in cash
In this article: ALXA